193 related articles for article (PubMed ID: 37155154)
1. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals chemokine self-feeding of myeloma cells promotes extramedullary metastasis.
Geng S; Wang J; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Wang W; Lyu X; Huang Y; Jing H
FEBS Lett; 2020 Feb; 594(3):452-465. PubMed ID: 31561267
[TBL] [Abstract][Full Text] [Related]
3. [Recent Research Progress of Extramedullary Plasmacytoma --Review].
Liu N; Zhao J; Yuan XI; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):607-611. PubMed ID: 37096543
[TBL] [Abstract][Full Text] [Related]
4. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
5. Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal.
Zhang J; Zhong Y
Hematol Oncol; 2015 Jun; 33(2):75-9. PubMed ID: 24395149
[TBL] [Abstract][Full Text] [Related]
6. Cytodiagnosis of extramedullary plasmacytomas.
Goel G; Rai S; Naik R; Gupta A; Baliga P; Sinha R
Acta Cytol; 2010; 54(3):255-8. PubMed ID: 20518407
[TBL] [Abstract][Full Text] [Related]
7. [Refractory multiple myeloma preceded by extramedullary plasmacytoma of lymph node--a case report and review of the literature].
Ise M; Nakaseko C; Sakai C; Takagi T
Rinsho Ketsueki; 1999 Jun; 40(6):505-10. PubMed ID: 10422289
[TBL] [Abstract][Full Text] [Related]
8. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma with extramedullary disease.
Oriol A
Adv Ther; 2011 Nov; 28 Suppl 7():1-6. PubMed ID: 22105527
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of 40 multiple myeloma patients with extramedullary plasmacytoma of the head.
Sun WJ; Zhang JJ; An N; Shen M; Huang ZX; Li X
J Int Med Res; 2016 Dec; 44(6):1462-1473. PubMed ID: 28322099
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.
Ghodke K; Shet T; Epari S; Sengar M; Menon H; Gujral S
Ann Diagn Pathol; 2015 Jun; 19(3):117-23. PubMed ID: 25842207
[TBL] [Abstract][Full Text] [Related]
12. Loss of
Zhu YX; Shi CX; Bruins LA; Jedlowski P; Wang X; Kortüm KM; Luo M; Ahmann JM; Braggio E; Stewart AK
Cancer Res; 2017 Aug; 77(16):4317-4327. PubMed ID: 28619709
[No Abstract] [Full Text] [Related]
13. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
Ndacayisaba LJ; Rappard KE; Shishido SN; Ruiz Velasco C; Matsumoto N; Navarez R; Tang G; Lin P; Setayesh SM; Naghdloo A; Hsu CJ; Maney C; Symer D; Bethel K; Kelly K; Merchant A; Orlowski R; Hicks J; Mason J; Manasanch EE; Kuhn P
Curr Oncol; 2022 Apr; 29(5):2954-2972. PubMed ID: 35621632
[TBL] [Abstract][Full Text] [Related]
14. FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.
Manfrini N; Mancino M; Miluzio A; Oliveto S; Balestra M; Calamita P; Alfieri R; Rossi RL; Sassoè-Pognetto M; Salio C; Cuomo A; Bonaldi T; Manfredi M; Marengo E; Ranzato E; Martinotti S; Cittaro D; Tonon G; Biffo S
Cancer Res; 2020 Nov; 80(21):4693-4706. PubMed ID: 32963011
[TBL] [Abstract][Full Text] [Related]
15. [Solitary plasmacytomas of bone and extramedullary plasmacytomas].
Yang D; Fan S; Tao H
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):41-4. PubMed ID: 8732111
[TBL] [Abstract][Full Text] [Related]
16. p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma.
Sheth N; Yeung J; Chang H
Leuk Res; 2009 Oct; 33(10):1357-60. PubMed ID: 19201468
[TBL] [Abstract][Full Text] [Related]
17. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone.
Knowling MA; Harwood AR; Bergsagel DE
J Clin Oncol; 1983 Apr; 1(4):255-62. PubMed ID: 6668499
[TBL] [Abstract][Full Text] [Related]
18. Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells.
Kanasugi J; Hanamura I; Ota A; Karnan S; Lam VQ; Mizuno S; Wahiduzzaman M; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Takami A
Cancer Sci; 2020 May; 111(5):1663-1675. PubMed ID: 32176823
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
Marchica V; Accardi F; Storti P; Mancini C; Martella E; Dalla Palma B; Bolzoni M; Todoerti K; Marcatti M; Schifano C; Bonomini S; Sammarelli G; Neri A; Ponzoni M; Aversa F; Giuliani N
Int J Hematol; 2017 Jan; 105(1):104-108. PubMed ID: 27699576
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetics of extramedullary manifestations in multiple myeloma.
Billecke L; Murga Penas EM; May AM; Engelhardt M; Nagler A; Leiba M; Schiby G; Kröger N; Zustin J; Marx A; Matschke J; Tiemann M; Goekkurt E; Heidtmann HH; Vettorazzi E; Dierlamm J; Bokemeyer C; Schilling G
Br J Haematol; 2013 Apr; 161(1):87-94. PubMed ID: 23368088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
